2 months ago
MNMD
AnalystsJonathan AschoffJonathan Aschoff's Stock Forecasts
AnalystsJonathan Aschoff
Analyst Ranking
Bottom 6%
#4315 out of 4563 analysts
Average Return
-30.51%
Win Rate
13%6 out of 47
Risk vs Reward
Poor
Good
Jonathan Aschoff's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ampio Pharmaceuticals IncAMPE | +418.28% | $139.49 | $722.96 | 2019-12-19 - 2020-12-18 | Strong Buy |
Inovio Pharmaceuticals IncINO | +234.59% | $41.28 | $138.12 | 2019-12-19 - 2020-11-10 | Strong Buy |
Inmune Bio IncINMB | +73.22% | $5.90 | $10.22 | 2019-12-19 - 2020-12-18 | Strong Buy |
Inovio Pharmaceuticals IncINO | +37.44% | $140.40 | $87.84 | 2020-11-17 - 2021-11-16 | Strong Sell |
Immix Biopharma IncIMMX | +28.88% | $2.32 | $2.99 | 2023-02-22 - 2024-02-21 | Strong Buy |
Jonathan Aschoff Analyst Color
Get additional color on Jonathan Aschoff's coverage of popular stocks
4 months ago
PBLA
Jonathan Aschoff's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Moleculin Biotech IncMBRX | 2 | Strong Buy | $40.00 | +819.54% | Maintains | 13 days ago |
Cellectar Biosciences IncCLRB | 4 | Strong Buy | $28.00 | +815.03% | Maintains | a month ago |
Tff Pharmaceuticals IncTFFP | 1 | Strong Buy | $44.00 | +1,361.79% | Maintains | a month ago |
Bio Path Holdings IncBPTH | 2 | Strong Buy | $40.00 | +1,506.43% | Maintains | a month ago |
Panbela Therapeutics IncPBLA | 3 | Strong Buy | $25.00 | +2,152.25% | Maintains | a month ago |
First Wave Biopharma IncFWBI | 4 | Strong Buy | $36.00 | +1,092.05% | Maintains | a month ago |
Mind Medicine IncMNMD | 1 | Strong Buy | $36.00 | +325.53% | Maintains | 2 months ago |
Tenax Therapeutics IncTENX | 3 | Strong Buy | $30.00 | +742.70% | Reiterates | 2 months ago |
Cyclacel Pharmaceuticals IncCYCC | 1 | Strong Buy | $21.00 | +813.04% | Maintains | 4 months ago |
Ontrak IncOTRK | 1 | Strong Buy | $4.00 | +1,094.03% | Initiates Coverage On | 5 months ago |
Zevra Therapeutics IncZVRA | 2 | Strong Buy | $25.00 | +448.25% | Reiterates | 7 months ago |
Acer Therapeutics IncACER | 2 | Hold | $1.50 | +66.67% | Downgrades | 8 months ago |
Clene IncCLNN | 1 | Strong Buy | $10.00 | +2,867.36% | Reiterates | 8 months ago |
Immix Biopharma IncIMMX | 2 | Strong Buy | $14.00 | +557.28% | Reiterates | 8 months ago |
Biorestorative Therapies IncBRTX | 2 | Strong Buy | $15.00 | +1,081.10% | Reiterates | 8 months ago |
Revelation Biosciences IncREVB | 2 | Strong Buy | $450.00 | N/A | Maintains | a year ago |
Helius Medical Technologies IncHSDT | 1 | Strong Buy | $250.00 | N/A | Initiates Coverage On | 2 years ago |
Ocugen IncOCGN | 1 | Strong Buy | $8.00 | N/A | Reinstates | 2 years ago |
Creative Medical Technology Holdings IncCELZ | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Biofrontera IncBFRI | 1 | Strong Buy | $400.00 | N/A | Initiates Coverage On | 2 years ago |
Seelos Therapeutics IncSEEL | 2 | Strong Buy | $240.00 | N/A | Upgrades | 3 years ago |
Notable Labs LtdNTBL | 1 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Aptevo Therapeutics IncAPVO | 2 | Strong Buy | $2,200.00 | N/A | Maintains | 3 years ago |
Novan IncNOVNQ | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Shoals Technologies Group IncSHLS | 1 | Strong Buy | $38.00 | N/A | Initiates Coverage On | 3 years ago |
Applied Dna Sciences IncAPDN | 1 | Strong Buy | $480.00 | N/A | Initiates Coverage On | 3 years ago |
Inovio Pharmaceuticals IncINO | 2 | Strong Sell | $96.00 | N/A | Downgrades | 3 years ago |
Entasis Therapeutics Holdings IncETTX | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 4 years ago |
Aridis Pharmaceuticals IncARDS | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 4 years ago |
Ampio Pharmaceuticals IncAMPE | 1 | Strong Buy | $1,200.00 | N/A | Initiates Coverage On | 4 years ago |
Inmune Bio IncINMB | 1 | Strong Buy | $13.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.